Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enteral G-CSF and EPO for Feeding Tolerance in Preterm Infants
NCT01441427Phase 2Completed
- Sponsor
- Ain Shams University
- Start
- Jan 2010
- Primary completion
- Apr 2011
- Modality
- Cytokines & Interferons
01
Overview
A Phase 2 trial of filgrastim, epoetin alfa in feeding intolerance, necrotizing enterocolitis (NEC), sponsored by Ain Shams University. Started Jan 2010; status: completed.
02
Drugs
filgrastimepoetin alfa
03
Conditions
feeding intolerancenecrotizing enterocolitis (NEC)
Beyond the preview
Go deeper on NCT01441427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01441427.